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Autoimmune, insulin-dependent diabetes mellitus in man is an inherited dis-
ease . Many studies have demonstrated (reviewed in references 1, 2) that genes
linked to the MHC of man contribute to the genetic susceptibility to diabetes .
>90% of Caucasian patients suffering from type 1 diabetes express the DR3
and/or DR4 antigens as compared with a60% expression in the total population .
Interestingly, DR3/DR4 heterozygotes are particularly susceptible to the devel-
opment of diabetes since up to 50% of type 1 diabetics possess this genotype as
compared with only 5% of the general population . The fine specificity of the
association of DR3 and DR4 with diabetes has recently been defined usingHLA
restriction endonuclease fragment length polymorphisms (3-5) and human T
lymphocyte clones that define DR subtypes (6, 7) .
The autoimmune response in type 1 diabetes is characterized by insulitis,
which is an inflammatory infiltrate affecting the islets of Langerhans . In a study
of 60 recent-onset type 1 diabetics, insulitis was present in 78% of patients (8) .
A persistence of memory cells specific for insulin-producing a cells is suggested
by theobservation that long-term insulin-dependent patients receivingapancreas
transplant from an identical twin will still reject the islet tissue even though the
original antigenic stimulus has been absent for years (9) .
Recently, two animal models exhibiting spontaneous diabetes mellitus have
been identified . The BB rat (10, 11) and the nonobese diabetic (NOD)' mouse
(12-16) both evidence the destructive autoimmune pancreatic insulitis that is
characteristic of human type 1 diabetes . In the BB rat model, diabetes can be
adoptively transferred with Con A-activated splenic lymphocytes obtained from
diabetic BB rats (17, 18). Further evidence supporting the autoimmune etiology
of diabetes in the BB rat is that treatment of BB rats with a combination of
immunosuppressive agents, which included cyclosporine A, glucocorticoids, and
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antiserum to rat lymphocytes, reduced the severity of spontaneous diabetes and
lowered the frequency of diabetes in susceptible animals (19). It has been shown
(20-22) that at least two independent genes or gene complexes are necessary for
the inheritance of diabetes in the BB rat, one gene that is closely linked to the
MHC and a second gene that is linked to the locus that controls the T cell
lymphopenia that is observed in the BB rat (20-22). However, recent data from
Like et al. (23) demonstrate that lymphopenia is not obligatory for the develop-
ment of diabetes in some lines of BB rats.
In the NOD mouse (12-16), the pancreatic inflammatory process begins at 4-
6 wk of age as a periductal and perivascular accumulation of lymphocytes. At 6-
8 wk of age, these lymphocytes begin to invade the islets and specifically destroy
insulin-producing 0 cells. Overt diabetes is observed beginning at 3 mo of age,
and by 7 mo of age, 70% of females and 40% of males have become diabetic. As
in the BB rat, this disease process appears to be immune based since T cells
obtained from diabetic mice induce diabetes in young, nondiabetic NOD mice
within 2-3 wk after transfer (24, 25). Unlike the BB rat, acute T cell lymphopenia
is not observed in the NOD mouse (26).
Recently, in crosses of NOD mice with normal C3H mice, Hattori et al. (27)
detected a recessive diabetogenic gene linked to the MHC of the NOD. The
development of overt diabetes depended on homozygosity of the NOD MHC in
addition to at least two other diabetogenic genes. It was also shown in this study
that the NOD fails to express an I-E product. The authors suggested that the
presence of the C3H I-E product in MHC heterozygous F2 and first-backcross
mice might prevent the development of diabetes. In a separate study, Leiter et
al. (28) have suggested that three recessive genes, including one located on
chromosome 9 and one linked to the MHC on chromosome 17, control the
development of diabetes in the NOD. Thus, an MHC-linked gene has been
implicated in the susceptibility to diabetes in man and in both animal models of
type 1 diabetes .
The present study was undertaken to define the minimum number of genes
or gene complexes that control the development of overt diabetes and insulitis
in the NOD mouse. We have specifically asked whether there is any influence
on either process by the MHC. To accomplish these goals, the NOD and
C57BL/10 (1310) strains were bred to produce the F,, F2, and F, X NOD first-,
second-, and third-backcross generations in which segregation of diabetes, insu-
litis, and MHC-encoded products was monitored. The B10 strain was chosen for
these studies since it does not develop overt diabetes or insulitis and, as observed
in the NOD strain, fails to express an I-E product (29) . We have found that the
development of diabetes and insulitis is under partially overlapping but distinct
genetic controls. Diabetes appears to be controlled by at least three independent
genes or gene complexes, one of which is linked to the MHC. In contrast, the
initiation of insulitis is determined by a single gene not linked to the MHC;
however, the severity of insulitis is greatly influenced by an MHC-linked gene .
Materials and Methods
Animals.
￿
A breeding nucleus of NOD mice (Kd, I-AN°°, Db) was kindly provided by
Dr. Yoshihiro Tochino (Aburabi Laboratories, Shionogi and Co., Osaka, Japan).
C57BL/10 (1310) (Kb, I-Ab, Db) and NZB/BINJ (NZB) (K
d, I-Ad, Dd) mice were obtainedWICKER ET AL .
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from The Jackson Laboratory (Bar Harbor, ME) . Mice were bred and maintained under
specific pathogen-free conditions and did not display antibody titers to Sendai or Mouse
Hepatitis viruses . Animals were tested biweekly for urinary glucose using Tes-Tape (Eli
Lilly and Co ., Indianapolis, IN) and were classified as diabetic after producing consistent
Tes-Tape values of 2:1+ .
MHC Typing.
￿
Dissociated spleen cells (106) from test mice were incubated with the
following mAbs to determine the MHC phenotype of the animals : anti-I-Al.d, H-2" (34-
5-3S [30] ; Litton Bionetics, Charleston, SC), which is not reactive with the NOD I-A
product, and anti-I-Ak ., .r .s.° (10-2.16 [31, 32], American Type Culture Collection, Rock-
ville, MD), which is reactive with the NOD I-A product but not the B10 I-A product . The
cells were washed once and then incubated with FITC-conjugated goat anti-mouse IgG
(Kirkegaard & Perry Laboratories, Inc ., Gaithersburg, MD) that had been absorbed with
Sepharose-conjugated mouse IgM protein, MOPC 104E (Litton Bionetics). Cells were
analyzed by flow cytometry on the FACS IV (Becton Dickinson Immunocytometry
Systems, Mountain View, CA) .
Histology.
￿
Pancreata obtained after killing mice were fixed either in formalin or Bouin's
solution and processed for paraffin embedment . Tissue sections (4 um) stained with H
and E were scrutinized for evidence of mononuclear cell inflammation . Fig . 1 illustrates
representative histological abnormalities of the pancreas that were encountered and the
classification scheme used to categorize the inflammatory lesions. Histology scores used
were : 0, no inflammatory cells observed in the pancreas ; 1, infiltrating cells observed in
periductal and/or perivascular locations ; 2, relatively small numbers of islet-associated
inflammatory cells are observed at the islet periphery ; and 3, moderate to severe inflam-
mation of the islet in which infiltrating mononuclear cells permeate islet tissues and
evidence of 0 cell necrosis is seen .
Histological classification of pancreatic tissues was made using the most severe inflam-
matory lesions detected . For example, an animal displaying both periductal inflammation
(score of 1) and severe insulitis (score of 3) received a score of 3 .
Statistical Analysis.
￿
Statistical significance was assessed by X2 analysis .
Results
Diabetes and Insulitis in NOD, B10, and (NOD X B10)F, Mice. It has been
previously shown (12-14) that the NOD strain develops insulitis and overt
diabetes . In ourNOD colony, 72% offemalesand 40% of males become diabetic
by 7 mo of age (Table I) . Histological examination of representative animals
exhibiting diabetes revealed the presence of islets undergoing active mononu-
clear cell inflammation and ,8 cell destruction (data not shown) . In addition, end-
stage islets characterized by an absolute loss ofcomponent (3 cells and regression
of insulitis were frequently observed . Pancreata from 16 female and male NOD
mice that had not become diabetic by 7 mo of age were histologically examined
and all received scores of 3 (Table I) . In contrast, B10 mice did not develop
diabetes, and pancreata obtained from B 10 animals did not display insulitis . Only
1 of 16 B10 mouse pancreata showed a small focal perivascular lymphocytic
infiltrate . We bred (NOD X B10)F, mice so we could monitor the inheritance of
diabetes and insulitis . None of the 200 F, mice observed developed diabetes,
which is consistent with a recessive inheritance of this phenotype (Table I) .
Insulitis was observed in only 1 of 64 (NOD X B10)F, mice . However, 17 of the
54 female F, mice examined had small pancreatic lymphoid infiltrations of the
exocrine pancreas that were associated with ductular and vascular elements but
not with the islets . Since one F, animal did develop insulitis and many others
appeared to exhibit inflammatory lesions mimicking the early stages of histolog-
ical abnormalities observed in young NOD mice, these data suggest that insulitis1642
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FIGURE 1 .
￿
Range of histological abnormalities used in the scoring of mouse pancreata (see
Materials and Methods) . (A) Normal islet morphology (grade 0) ; (B) periductular and perivas-
cular mononuclear cell inflammation (grade 1) ; (C) early stage insulitis. Small numbersof islet-
associated inflammatory cells are peripherally located (grade 2); (D) severe insulitis . Inflam-
matory cells surround andpermeate the islet . 0 cell necrosis is seen (grade 3) . H andEstaining.
All figures approximately x 600 .WICKER ET AL .
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TABLE I
Prevalence ofDiabetes and Insulitis in NOD, B10, and (NOD X B10)F, Mice
Ages of mice exceeded 7 mo at the time of analysis . The severity of pancreatic inflammation was
scored as described in the Materialsand Methods section . The 16NOD mice histologically examined
were not diabetic .
TABLE II
Prevalence ofDiabetes in (NOD X B10)F2 and First and Second (F, X NOD) BackcrossMice
Mice exhibited diabetes or were >7 mo old at thetime ofanalysis .
* All mice were histologically examined, except those in these groups in which 15 of 84 second-
backcrossNODMHC homozygous females and 10 of 79 males were examined .
is controlled by an incompletely dominant gene that appears to have low pene-
trance in the Fl .
Segregation ofDiabetes and Insulitis in the (NOD X B10)F2 Generation .
￿
Because
of the known association of theMHC with type I diabetes both in man (1-7) and
the BB rat (21, 22), spleen cells from members of the(NOD X B10)F2 generation
were typed at the I-A region . As described in Table II, none of the 61 female
(<1 .6%) or 54 male (<1.9%) F2 mice became diabetic by 7 mo of age . These
Strain Sex MHC type
Diabetes
n Percent
Histology score
(percent of total examined)
0 1 2 3
F2 F NOD 0/21 0 0 33 43 24
NOD/b 0/27 0 26 22 37 15
b 0/13 0 46 15 31 8
M NOD 0/10 0 20 40 40 0
NOD/b 0/32 0 37 41 22 0
b 0/12 0 67 25 0 8
First BC F NOD 4/32 12 .5 6 16 25 53
NOD/b 0/29 0 21 31 34 14
M NOD 1/20 5 30 15 20 35
NOD/b 0/31 0 45 23 26 6
Second BC F NOD* 41/84 48.8 13 0 7 80
NOD/b 1/21 4.8 19 19 38 24
M NOD* 16/79 20.3 0 0 0 100
NOD/b 0/16 0 25 50 12.5 12.5
Third BC F NOD 8/11 72.7 0 0 9 91
NOD/b 0/27 0 8 15 44 33
Pancreas histology Diabetes
Strain Sex Number Histology score
observed 0 1 2 3
n Percent
NOD F 7 0 0 0 100 78/108 72
NOD M 9 0 0 0 100 30/76 40
BIO F 11 91 9 0 0 0/50 0
1310 M 5 100 0 0 0 0/50 0
F, F 54 67 31 2 0 0/100 0
F, M 10 90 10 0 0 0/100 01644
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data are consistent with the hypothesis that overt diabetes is controlled by more
than one gene in the NOD (see complete analysis in Table 111) . In contrast to
the lack of diabetes, most F2 mice displayed pancreatic inflammatory lesions
including mild to severe insulitis . This high frequency of mononuclear cell
infiltration in the F2 suggests that pancreatic inflammation and insulitis are
controlled by a single dominant or incompletely dominant gene . These data
obtained from the F2 generation indicate that fewer genes are required for the
expression of pancreatic inflammation and insulitis as compared with the expres-
sion of diabetes .
In female F2 mice, grade 2 or 3 insulitis was observed in 67% of mice
homozygous for the NOD MHC, 52% of NOD/1310 MHC heterozygotes, and
39% of 1310 MHC homozygotes . A similar pattern of insulitis was observed in
male F2 mice, since 40% ofNODMHC homozygotes, 22% of NOD/1310 MHC
heterozygotes, and 8% of 1310 MHC homozygotes had lymphocytic infiltration
associated with islets . Although theMHC appeared to influence the development
of insulitis in the F2 generation, the differences in the incidences of insulitis in
both the female and male MHC homozygous and heterozygous groups were not
statistically significant . Of particular interest is the appearance of islet-associated
inflammation in 1310 MHC homozygotes, which suggests that insulitis in the
NOD mouse does not require a gene linked to theNODMHC.
Segregation of Diabetes and Insulitis in the [(NOD X B10)F l X NOD] First-
Backcross Generation. In the first backcross of (NOD X B10)F, mice to NOD
mice, 4 of 61 females and 1 of 51 males were overtly diabetic by 7 mo of age
(Fable II) . This low incidence of diabetes in the first-backcross generation
strongly suggests that multiple genes or gene complexes control thedevelopment
4 diabetes in the NOD. It is likely that one of the genes necessary for the
development of diabetes is linked to the NODMHC since 5 of 52 NODMHC
homozygotes became diabetic as compared with 0 of 60 NOD/1110 MHC
heterozygotes (p < 0.05) .
Insulitis was observed in both NOD MHC homozygotes and NOD/1110 MHC
heterozygotes in the first-backcross generation . Insulitis among first-backcross
females was more frequent inNODMHC homozygotes (78%) as compared with
NOD/1310 MHC heterozygotes (48%) (p < 0.05) . In addition, fewer female
heterozygotes (14%) exhibited grade 3 inflammation as compared with homo-
zygotes (53%) (p < 0.005). Similarly, severe insulitis (grade 3) among first-
backcross male mice was observed in 35% of the NOD MHC homozygotes and
in only 6% of the NOD/1110 MHC heterozygotes (p < 0.025) . Thus, the MHC
appears to influence both the incidence and severity of insulitis in the first-
backcross generation since two doses of the NOD MHC allowed for a more
aggressive autoimmune response than that observed in NOD/1310 MHC heter-
ozygotes .
Diabetes and Insulitis in the [(NOD X B10)Fl X NOD] Second-Backcross Genera-
tion . In the second-backcross generation, a large increase in the number of
mice becoming diabetic was observed (Table I1) . Among the backcross mice that
were homozygous for the NOD MHC, 49% of the females and 20% of males
became diabetic, approximately half the incidence observed in theNOD parental
strain . The influence of sex on the development of diabetes in the NOD strainWICKER ET AL .
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was evident in the second-backcross generation since there was a significant
difference in the incidence of diabetes in the two sexes (p < 0.001) .
One of 21 (<5%) NOD/1110 MHC heterozygous females became diabetic,
demonstrating that although MHC heterozygosity protects most animals from
diabetes (p < 0.001), NODMHC homozygosity is not obligatory for the devel-
opment of diabetes . Alternatively, a crossover may have occurred on chromo-
some 17 between the I-A region and the MHC-linked gene essential for the
expression of diabetes . We favor the former possibility since 24% of the
NOD/1310 MHC heterozygous females in the second backcross exhibited grade
3 insulitis, indicating that a vigorous immune response can occur in the MHC
heterozygotes .
Insulitis in both male and female second-backcross mice was greatly influenced
by the MHC . 80% of female NOD MHC homozygotes and 100% of the males
displayed severe insulitis (score of 3), as compared with only 24% of female (p <
0.005) and 12.5% of male (p < 0.001) MHC heterozygotes . However, as
mentioned above, NOD MHC homozygosity increased the incidence of severe
insulitis over that observed in the NOD/1110 MHC heterozygotes but was not
obligatory for the development of inflammatory lesions.
Diabetes and Insulitis in the Third-Backcross Generation .
￿
In the third-backcross
generation, analysis of diabetes and insulitis was limited to females (Table 11) .
The prevalence of diabetes in NOD MHC homozygous third-backcross mice
(73%, n = 11) reached that of parental NOD female mice (72%, Table 1) . In
addition, 91% of the homozygotes received a score of 3 for pancreatic histology .
In contrast, all mice that were heterozygous at the MHC failed to develop
diabetes (n = 27), confirming the previous conclusion that NODMHC homozy-
gosity is usually required for the expression of diabetes (p < 0.001) . Although
77% of the MHC heterozygotes developed insulitis, only 33% developed grade
3 insulitis, which is much lower than the 91% incidence of severe insulitis
observed in the NODMHC homozygotes (p < 0.005). Thus, as seen in the first-
and second-backcross generations, the development of diabetes depended on
NODMHC homozygosity whereas the initiation of insulitis did not . Since>70%
of the NOD homozygotes became diabetic and nearly all scored a 3 in pancreatic
histology, the data strongly suggest that permissive alleles are present at the non-
MHC-linked diabetogenic loci in most of the third-backcross mice, including the
MHC heterozygotes . Therefore, we can conclude that the presence of a non-
NOD MHC haplotype in heterozygotes at the MHC attenuates the pancreatic
inflammatory process such that most heterozygotes do not develop the severe
insulitis that ultimately results in widespread ,Q cell destruction observed ofNOD
MHC homozygotes .
Estimate ofthe Minimum Number of Genes Required for the Expression ofDiabetes
in theNOD. The development of diabetes in the NOD is clearly linked to one
known genetic locus, the MHC (Table 11) . This locus acts primarily in a recessive
fashion since only 1 of the 71 first-, second-, and third-backcross male and female
mice becoming diabetic in this study was heterozygous at the MHC (1 of 124
MHC heterozygotes, 70 of 226 MHC homozygotes ; p < 0.0001) . The recessive
nature of the MHC-linked diabetogenic gene is derived from the ability ofNOD
MHC homozygotes to develop both a high incidence and severity of insulitis,
whereas NOD/1110 MHC heterozygotes exhibit less severe abnormalities .1646
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TABLE III
Estimation of the Number of Genes Requiredforthe Expression ofDiabetes in the NOD
Expected values have been calculated assuming that two recessive genes in addition to NODMHC
homozygosity are needed to produce overt diabetes and that the diabetes phenotype has a
penetrance of 0.7 in females and 0.4 in males. Goodness of fit was assessed using the X2 test . For
all X2 values determined, p> 0.05, which indicates that expected and observed values were not
significantly different .
* The expected values in the F2 generation were too small for X 2 analysis .
Since NODMHC homozygosity appears to be nearly essential for the expres-
sion of diabetes, the incidence of overt diabetes was subjected to
X2 analysis only
in the NOD MHC homozygotes of the first-, second-, and third-backcross
generations (Table III) ; expected values in the F2 generation were too small for
valid analysis . In determining the expected values in this analysis, it was assumed
that diabetes had a 0.7 penetrance in femalesand 0.4 in males . Penetrance values
were based on the disease incidence in the NOD parental strain of 72% for
females and 40% for males (Table I) . No significant differences were found
between observed and expected incidences of diabetes in the first-, second-, and
third-backcross generations when it was assumed that two recessive unlinked
genes were necessary for the development of diabetes in NOD MHC homozy-
gotes . Although a
X2 value was not determined for the F2 generation, the lack
of diabetes in the F2 is consistent with the hypothesis that two recessive diabeto-
genic genes in addition to the MHC control diabetes . Significant differences
between observed and expected incidences of diabetes were observed in the
backcross generations when it was assumed that 1 or 3 recessive genes controlled
the development of diabetes in NOD MHC homozygotes (calculations not
shown) .
Based on this analysis, we hypothesize that three functionally recessive genes
or gene complexes control the development of diabetes, one linked to the MHC
of the NOD and two that are not linked to the MHC. Although there may in
Strain Sex MHC type
Overt
Actual
diabetes
Expected
X
2
F2 F NOD 0/21 0.92/21 ND*
NOD/b 0/27
b 0/13
M NOD 0/10 0.25/10 ND*
NOD/b 0/32
6 0/12
First BC F NOD 4/32 5.60/32 0.554
NOD/b 0/29
M NOD 1/20 2.00/20 0.556
NOD/b 0/31
Second BC F NOD 41/84 32.9/84 3.278
NOD/b 1/21
M NOD 16/79 17.7/79 0.210
NOD/b 0/16
Third BC F NOD 8/11 5.9/11 1 .612
NOD/b 0/16WICKER ET AL .
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TABLE IV
Segregation ofSevere (Grade 3) Insulitis and Diabetes in NODMHCHomozygous Females
Mice with grade 3
￿
Expected*
￿
Grade 3 mice with
￿
Expected* Genera- insulitis
￿
diabetes
tion
* Expected values for grade3 insulitis were calculated assumingthat a single recessive gene controlled
this phenotype . Goodness of fit was determined using the X test . All X 2 values were <0.889, p>
0.25 .
$Expected values for mice that expressed grade 3 insulitis to become diabetic were calculated
assuming that a single recessive gene controlled this phenotype . Penetrance of the diabetes
phenotype was assumed to be 0.7 . All X 2 values were <2.01, p>0.10 .
4Theexpected value in the F2 generation was too small for X 2 analysis.
fact be a more complex genetic control of diabetes in the NOD, the three-
recessive-genes hypothesis is the simplest model consistent with the data obtained .
In addition, ourhypothesis represents a minimal estimate of the number of genes
involved since the analysis would not detect additional dominant genes or genes
linked to those observed in this study .
Analysis of Genes Influencing the Development of Insulitis and Diabetes .
￿
From
our analysis of the backcross generations we found that the MHC significantly
influenced both the incidence and severity of insulitis (Table 11) . The animals in
each generation expressing the most severe levels of insulitis were female NOD
MHC homozygotes . Since the penetrance of the gene controlling the insulitis
phenotype appeared to be the greatest in this group (assumed to be 100% in the
following analysis), the genetic control of insulitis was studied in this subset of
mice (Table IV) .
Analysis of female NODMHC homozygotes for grade 3 insulitis revealed that
24% of F2, 53% of BC1, 80% of BC2, and 91% of BC3 mice expressed this
phenotype . X 2 analysis of these data showed no significant difference between
observed and expected frequencies of grade 3 insulitis when it was assumed that
two doses of the NOD-derived allele were required for the development of
severe insulitis. Ideal expected values for grade 3 insulitis using these assumptions
are 25, 50, 75, and 87.5% for the F2, BC1, BC2, and BC3 generations, respec-
tively. Whereas two doses of the NOD-derived allele appear to determine the
development of severe insulitis, the presence of one dose of the permissive allele
allows for a less severe autoimmune response in the pancreas (Table I1) . There-
fore, this gene that influences the development of insulitis appears to be incom-
pletely dominant and is most likely one of the non-MHC-linked, functionally
recessive genes required for the expression of diabetes discussed in the previous
section . It is possible that this gene which controls severe insulitis is the same
incompletely dominant gene discussed earlier in the Results section that controls
the initiation of pancreatic inflammation in the NOD.
Since severe insulitis is required for the development of diabeteswe considered
whether all mice with severe insulitis become diabetic or only a subset of such
mice develop diabetes . Therefore,NODMHC homozygous female mice express-
n Percent n Percent n Percent n Percent
F2 5/21 24 5.25/21 25 0/5 <20 0.88/51 17.6
BC1 17/32 53 16/32 50 4/17 23.5 5.95/17 35.0
BC2 67/84 80 63/84 75 41/67 61 .2 35.2/67 52.5
BC3 10/11 91 9.6/11 87 .5 8/10 80.0 6.1/10 61 .01648
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ing severe (grade 3) insulitis in the F2 and backcross generations were assessed
for the prevalence of overt diabetes. The percentage ofmice expressing grade 3
insulitis that had become diabetic was <20% in F2, 23.5% in BC1, 61 .2% in BC2,
and 80.0% in BC3 mice. Assuming a penetrance for diabetes of 0.7, as in the
parental female NOD, and that a single recessive gene controls the development
of diabetes in mice expressing severe insulitis, the expected values for diabetes
are 17.6%, 35.0%, 52.5%, and 61.0% for the F2, BC1, BC2, and BC3 genera-
tions, respectively. By X2 analysis, no significant differences were found between
the expected and observed frequencies ofdiabetes in the backcross generations.
The expected values were too small for X2 analysis of the F2 generation data.
Thus, these data support the hypothesis that a recessive gene is important in the
development ofovert diabetes from severe insulitis.
Lack of Diabetes and Insulitis in the (NOD X NZB)F, .
￿
Since diabetes is not
observed in F, mice bred from the NOD and normal mouse strains such as B10
(the current study), B6 (13), C3H (27), or NON (28), F, progeny were produced
with the NZB, a murine strain that exhibits autoimmune disorders, in an attempt
to determine if diabetes and insulitis are recessive even in the presence of
autoimmune alleles contributed by the NZB. It has been demonstrated (33) that
the NZB mouse spontaneously develops autoimmune hemolytic anemia, immune
complex glomerulonephritis, and abnormal proliferation of B lymphocytes. In
addition, mononuclear cell infiltrates have been identified (34) in the lung, liver,
kidney, salivary gland, mesentery, and pancreas ofadult NZB mice.
Overt diabetes was not found in any ofthe 75 (NOD X NZB)F, mice that were
observed for a period of 1 yr. Analysis of pancreata examined from 7 female
NZB and 25 female (NOD X NZB)F, mice that were >7 mo old revealed that 6
of 7 NZB and 24 of 25 (NOD X NZB)F, mice displayed inflammatory lesions.
The histology observed in the F, resembled that of the NZB parent since
mononuclear cell infiltrates were found in the exocrine parenchyma rather than
in the islets as seen in the NOD. The pattern ofinflammation observed has been
previously described by Seemayer and Colle (34) and was distinct from that
found in NOD mice. Thus, even when the NOD is crossed with another
autoimmune strain such as the NZB, it appears that severe insulitis, which
culminates in nearly complete 0 cell destruction and diabetes, is a recessive
phenotype.
Discussion
In this study we have presented data that are consistent with the hypothesis
that a minimum of three functionally recessive genes or gene complexes control
the development ofdiabetes in the NOD mouse. One ofthese three diabetogenic
genes was shown to be linked to the MHC region ofthe NOD mouse. In contrast
to the three-gene control for overt diabetes, insulitis appears to be determined
by a single, incompletely dominant gene or gene complex that is not linked to
the MHC. Since the development ofdiabetes in the NOD is always preceded by
the appearance of severe insulitis and fl cell destruction, our data suggest that
two of the three functionally recessive diabetogenic genes are accounted for by
a non-MHC-linked, incompletely dominant gene controlling the development
of severe insulitis and an MHC-linked gene that modulates the incidence and
severity of this insulitis. The third diabetogenic gene appears to act after theWICKER ET AL .
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development of severe insulitis and may control a protective suppressor T cell
response to the autoimmune process. The incompletely dominant gene observed
in F, and F2 animals that controls the initiation of pancreatic inflammation and
insulitis is likely to be identical to the incompletely dominant gene responsible
for the development of severe insulitis in NODMHC homozygotes in the F2 and
backcross generations . We are currently fixing the gene that appears to initiate
insulitis onto the B10 background to address this question .
In our analysis of the segregation of the diabetes and insulitis phenotypes, it
became apparent that many animals did not express insulitis but did show
abnormal pancreatic inflammatory lesions that resembled those observed in
young NOD mice . This was particularly apparent in F2 mice and in MHC
heterozygotes in thebackcross generations in whichanimals displayed histological
abnormalities in their pancreata ranging from mild periductular infiltrates to
severe insulitis (Table II) . It is likely that this wide range of abnormalities results
from the same genetically controlled initiating event and that other genes (such
as theMHC) influence the progression of the autoimmune response . In addition,
this histological evidence indicates the the genetic ability to develop insulitis is
not equivalent to the genetic ability to develop diabetes . Additional genes
apparently determine whether the insulitis proceeds to a point at which most ,Q
cells are destroyed and diabetes results.
A surprising result in light of the extensive pancreatic inflammation and
insulitis observed in the F2 generation was the low incidence of these abnormal-
ities in the (NOD X B10)FI. Only 33% of female and 10% of male (NOD X
B10)F I mice displayed pancreatic lymphocytic infiltration (Table I) as compared
with 74% of female (p < 0.005) and 63% of male (p < 0.025) F2 mice
heterozygous at the MHC (Table 1I) . These data suggest that additional loci
influence the penetrance of the gene that initiates pancreatic inflammation and
insulitis.
The single exception to recessive MHC-linked genetic control of diabetes was
observed in the second-backcross generation in which an H-2"°D/H-26 heterozy-
gote became diabetic (Table II) . Either this heterozygote represents a crossover
event between the NOD I-A region and the MHC-linked NOD diabetogenic
gene, or this animal demonstrates that in rare cases the severe insulitis observed
in some MHC heterozygotes can proceed to overt diabetes . We favor the latter
possibility since it is likely that the MHC-linked gene controlling diabetes is I-A .
We have recently discovered (Wicker, L. S . and B. J. Miller, unpublished
observations) a diabetic fifth-backcross female mouse that was heterozygous at
both the K and I-A regions. An analysis of the prevalence of diabetes in the
progeny of this animal will support only one of the above hypotheses . A high
incidence of diabetes in the MHC heterozygous progeny of this diabetic MHC
heterozygous female will suggest a crossover event, whereas a low incidence will
support the hypothesis that in rare cases MHC heterozygotes can become
diabetic .
The functions of the individual diabetogenic genes in theNOD that have been
identified in this analysis remain to be defined . The stimulus that initiates
pancreatic lymphocytic infiltration does not appear to come from the external
environment since diabetes is observed in gnotobiotic NOD mice (Wicker, L. S.,1650
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andB. J . Miller, unpublished observations) . The reaction to the antigenic event(s)
appears to be controlled by an incompletely dominant, non-MHC-linked gene .
After the initiating event responsible for pancreatic inflammation, a gene (or
genes) linked to the MHC influences the progression of the pancreatic inflam-
mation to insulitis . It has been suggested (35, 36) that antigen-presenting la
molecules, which are encoded by the I-A region in the MHC, influence the
immune response by determining whether helper or suppressor cells will domi-
nate in response to a given antigen . It is possible that helper cells dominate in
backcross animals that are homozygous for the NOD MHC, whereas suppressor
cells are dominant in MHC heterozygotes .
It is also within this balance of help and suppression that the non-MHC-linked
recessive gene controlling the development of overt diabetes from insulitis in the
NOD (Table IV) might function . This gene may be important in setting the
response level of the immune system to the presentation of foreign or self
antigens by I-A gene products . For example, in the immune response to the
defined protein hen egg-white lysozyme (HEL), most H-26 strains are nonre-
sponders due to the induction of suppressor cells (37) . However, the BALB.13,
which is H-26, responds to HEL. Genetic analysis of recombinant inbred lines
has defined a non-MHC-linked gene, Ir-2 on chromosome 2, which appears to
tip the balance of the immune response from suppression to help (38, 39) .
In addition to the three diabetogenic genes or gene complexes that were
defined in this study, there is also an effect of sex on the development ofdiabetes
since twofold more female NOD and NODMHC homozygous backcross mice
become diabetic as compared with males . This sex difference appears to be
caused by the differential effects of male and female sex hormones on the
immune system with male hormones possibly augmenting the suppressor arm of
the immune response (40, 41) . The importance of immune suppression in the
NOD mouse has been suggested by studies (42) in which treatment with cyclo-
phosphamide (which is thought to preferentially eliminate suppressor T cells)
induced diabetes . Thus it is tempting to postulate that a balance of suppression
and help exists within NOD mice . When suppressor cells are partially eliminated
or impaired by cyclophosphamide treatment this balance shifts in favor of helper
functions that may in turn induce increased activity of cytotoxic effector cells.
Our study is in agreement with the recent reports by Hattori et al . (27) and
Leiter et al . (28) demonstrating the importance of theMHC in the development
of overt diabetes in the NOD. Hattori et al . (27) analyzed F2 and first-backcross
mice of the (NOD X C3H) cross. Since the C3H strain expresses an la antigen
encoded by the I-E region, it was possible that the failure ofMHC heterozygotes
to become diabetic was due to the presence of an I-E product . Our study
demonstrates that this is unlikely since when NOD is crossed with 1310, a strain
that does not express an I-E product, H-210DIH-26 heterozygotes still fail to
become diabetic . Hattori et al . (27) indicated that their data were consistent with
the hypothesis that two or more diabetogenic genes, in addition to an MHC-
linked recessive gene, are required for the expression of diabetes . However,
histological data describing the segregation of insulitis were not presented in
their study .
Our data underscore the importance of MHC-linked and non-MHC-linked
diabetogenic genes in the NOD model of diabetes . The specific initiating eventsWICKER ET AL.
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of the autoimmune insulitis as well as the mechanisms of action of the diabeto-
genic genes that control the progression of insulitis to diabetes remain to be
elucidated.
Summary
Genetic analysis of the development of diabetes and insulitis has been per-
formed in the nonobese diabetic (NOD) mouse strain, a model of insulin-
dependent (type I) diabetes mellitus. (NOD x C57BL/10)F,, F2, and (F, x NOD)
first-, second-, and third-backcross generations were studied. The data obtained
were consistent with the hypothesis that diabetes is controlled by at least three
functionally recessive diabetogenic genes, or gene complexes, one of which is
linked to the MHC of the NOD. In contrast, pancreatic inflammation leading to
insulitis was found to be controlled by a single incompletely dominant gene.
One of the two diabetogenic loci that is not linked to the MHC appears to be
essential for the development of severe insulitis. This diabetogenic gene may be
identical to the gene that controls the initiation of the autoimmune response that
progresses to insulitis. Although this gene appears to be functionally recessive in
its control of diabetes, it is incompletely dominant in its control of insulitis. The
MHC-linked diabetogenic gene, although not required for the development of
insulitis, apparently influences the progression of the autoimmune response since
NOD MHC homozygotes in the backcross generations displayed the highest
incidence and most severe cases of insulitis. Interestingly, we have found two
MHC heterozygous backcross females that have become diabetic, suggesting that
either the MHC-linked diabetogenic gene is not strictly recessive or that a
recombination event has occurred between the diabetogenic gene and the K or
I-A regions of the MHC. The third diabetogenic locus appears to influence the
progression of severe insulitis to overt diabetes. In animals homozygous at this
locus, diabetes may result from a decreased ability to develop a protective
suppressor response to the autoimmune process.
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